ECSP10010625A - Derivados de iminopiridina y uso de los mismos - Google Patents

Derivados de iminopiridina y uso de los mismos

Info

Publication number
ECSP10010625A
ECSP10010625A EC2010010625A ECSP10010625A ECSP10010625A EC SP10010625 A ECSP10010625 A EC SP10010625A EC 2010010625 A EC2010010625 A EC 2010010625A EC SP10010625 A ECSP10010625 A EC SP10010625A EC SP10010625 A ECSP10010625 A EC SP10010625A
Authority
EC
Ecuador
Prior art keywords
iminopiridine
derivatives
same
compound
prophylactic
Prior art date
Application number
EC2010010625A
Other languages
English (en)
Inventor
Masato Yoshida
Yasuhisa Kohara
Nobuki Sakauchi
Ayumu Sato
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of ECSP10010625A publication Critical patent/ECSP10010625A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Se describe un compuesto el cual tiene una excelente actividad selectiva superior como antagonista del receptor adrenérgico 1D y por lo tanto es útil como un agente profiláctico/terapéutico para el tratamiento de una enfermedad del tracto urinario inferior y similares. Se describe específicamente un compuesto representado por la fórmula (I) [en donde cada símbolo es como se definió en la descripción] o una de sus sales.
EC2010010625A 2008-04-23 2010-11-23 Derivados de iminopiridina y uso de los mismos ECSP10010625A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008113130 2008-04-23

Publications (1)

Publication Number Publication Date
ECSP10010625A true ECSP10010625A (es) 2011-03-31

Family

ID=41216865

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010625A ECSP10010625A (es) 2008-04-23 2010-11-23 Derivados de iminopiridina y uso de los mismos

Country Status (16)

Country Link
US (1) US20110039892A1 (es)
EP (1) EP2269989A4 (es)
JP (1) JPWO2009131135A1 (es)
KR (1) KR20110005277A (es)
CN (1) CN102066328A (es)
AU (1) AU2009238999A1 (es)
BR (1) BRPI0911464A2 (es)
CA (1) CA2722031A1 (es)
CO (1) CO6260133A2 (es)
CR (1) CR11766A (es)
DO (1) DOP2010000322A (es)
EA (1) EA201071228A1 (es)
EC (1) ECSP10010625A (es)
IL (1) IL208824A0 (es)
MX (1) MX2010011651A (es)
WO (1) WO2009131135A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470859B2 (en) * 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
EP3318554B1 (en) * 2011-08-26 2021-11-03 Meiji Seika Pharma Co., Ltd. Method for producing pest control agent
CA3237229A1 (en) * 2021-11-15 2023-05-19 Narasimha Murthy Cheemala Bicyclic heteroaromatic compounds and their use as pest control agents

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4840544B1 (es) 1970-04-24 1973-12-01
DD106377A1 (es) 1973-06-18 1974-06-12
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.
GR78245B (es) 1980-09-12 1984-09-26 Ciba Geigy Ag
FR2540109B1 (fr) * 1983-01-28 1985-08-30 Logeais Labor Jacques Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique
DD263759A1 (de) 1986-04-01 1989-01-11 Akad Wissenschaften Ddr Verfahren zur herstellung von 1-substituierten 2-imino-5-(pyrid-4-yl)-1,2-dihydro-pyridin-3-carbonsaeure-derivaten
US5252498A (en) * 1989-08-28 1993-10-12 Semiconductor Energy Laboratory Co., Ltd. Method of forming electronic devices utilizing diamond
DE4021439A1 (de) * 1989-12-14 1991-06-20 Bayer Ag 2-iminopyridin-derivate
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
JP2992677B2 (ja) 1995-06-05 1999-12-20 武田薬品工業株式会社 骨形成促進医薬組成物
ZA991315B (en) * 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
US6153614A (en) * 1998-07-16 2000-11-28 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
CA2338037A1 (en) * 1998-07-17 2000-01-27 Synaptic Pharmaceutical Corporation Compounds specific for the human .alpha.1d adrenergic receptor and uses thereof
DE19845202A1 (de) * 1998-10-01 2000-04-06 Wella Ag Haarwuchsmittel
EP1415987B1 (en) * 2000-10-20 2007-02-28 Eisai R&D Management Co., Ltd. Nitrogenous aromatic ring compounds as anti cancer agents
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
US7375100B2 (en) * 2003-06-04 2008-05-20 Pfizer Inc 2-amino-pyridine derivatives useful for the treatment of diseases
ES2241496B1 (es) * 2004-04-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridina.
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
TW200700392A (en) * 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
ES2303758B1 (es) * 2006-02-20 2009-08-13 Laboratorios Almirall S.A. Nuevos derivados de piridin-3-amina.
US8470859B2 (en) * 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
JP4117008B2 (ja) 2006-10-30 2008-07-09 シャープ株式会社 暗号化装置
WO2009014637A2 (en) * 2007-07-19 2009-01-29 Schering Corporation Heterocyclic amide compounds as protein kinase inhibitors
BRPI0908906A2 (pt) * 2008-03-21 2019-09-24 Novartis Ag compostos heterocíclicos e usos dos mesmos
CL2009000964A1 (es) * 2008-04-23 2010-03-26 Takeda Pharmaceuticals Co Compuestos derivados de 1-aril-2-imino-1,2-dihidropiridina-3-carboxamida, antagonista del receptor adrenergico alfa 1d, composicion farmaceutica que los comprende; y su uso para el tratamiento o profilaxis de enfermedades del tracto urinario inferior.
US8481569B2 (en) * 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof

Also Published As

Publication number Publication date
CA2722031A1 (en) 2009-10-29
CR11766A (es) 2010-12-15
EP2269989A1 (en) 2011-01-05
DOP2010000322A (es) 2011-01-31
MX2010011651A (es) 2010-12-06
EP2269989A4 (en) 2011-05-25
US20110039892A1 (en) 2011-02-17
CN102066328A (zh) 2011-05-18
KR20110005277A (ko) 2011-01-17
EA201071228A1 (ru) 2011-06-30
JPWO2009131135A1 (ja) 2011-08-18
BRPI0911464A2 (pt) 2016-07-12
WO2009131135A1 (ja) 2009-10-29
AU2009238999A1 (en) 2009-10-29
IL208824A0 (en) 2011-01-31
CO6260133A2 (es) 2011-03-22

Similar Documents

Publication Publication Date Title
ECSP10010626A (es) Derivados de iminopiridina y su uso
ECSP088210A (es) Bencimidazoles sustituidos y métodos de preparación
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
CO6541645A2 (es) Compuestos de indol y su uso farmaceutico
CR20120448A (es) Compuesto heterocíclico
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CU20100159A7 (es) Compuestos
UY32882A (es) (heteroarilmetil) tiohidantoínas sustituidas
UY29633A1 (es) Derivados de oxindol
UY31127A1 (es) Ligandos de oxiadazol del receptor metabotropico para el glutamato y su utilizacion como potenciadores - 841
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
UY30835A1 (es) 8-alquinilxantinas y derivados
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
UY31383A1 (es) N-aroil-n??-(6-(opcionalmente sustituido) alquilsulfonibenzotiazol-2-il)ureas
DE602005023197D1 (de) -muscarinrezeptors
CR20110387A (es) Microbiocidas nuevos
CL2011003154A1 (es) Compuestos derivados de pirazinooxazepina, activador del receptor de serotonina 5-ht2c, composicion farmaceutica que los comprende; y su uso en el tratamiento y/o profilaxis de sintomas del aparato urinario inferior, obesidad y/o prolapso de organos.
ECSP088740A (es) Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios
GT200600081A (es) Derivados de acetilenno
CU20120081A7 (es) Nuevas formas polimorfas de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo
DOP2010000322A (es) Derivados de iminopiridina y uso de los mismos
ECSP088621A (es) Derivados de triazoloanilinopirimidina para uso como agentes antivirales
CR20150148A (es) Azaindolinas
CL2008003332A1 (es) Compuestos derivados de ciclopentano sustituido, como agentes hipotensores oculares; composicion oftalmologicamente aceptable; y uso para el tratamiento del glaucoma.
CO6382113A2 (es) Compuestos quimicos